1. Regeneration of diaphragm with bio-3D cellular patch
- Author
-
Yusuke Yanagi, Xiu Ying Zhang, Tomoaki Taguchi, Kouji Nagata, Zijing Sheng, and Koichi Nakayama
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Diaphragm ,Biophysics ,Diaphragmatic breathing ,Bioengineering ,Cell Line ,Biomaterials ,Neovascularization ,03 medical and health sciences ,Defect closure ,Tissue engineering ,Human Umbilical Vein Endothelial Cells ,Animals ,Humans ,Regeneration ,Medicine ,Clinical efficacy ,Tissue Engineering ,Tissue Scaffolds ,business.industry ,Congenital diaphragmatic hernia ,Histology ,medicine.disease ,Rats, Inbred F344 ,Rats ,Surgery ,Transplantation ,030104 developmental biology ,Mechanics of Materials ,Printing, Three-Dimensional ,Ceramics and Composites ,medicine.symptom ,Hernias, Diaphragmatic, Congenital ,business - Abstract
Neonates with congenital diaphragmatic hernia often require surgical defect closure with a patch. Alternatives to native diaphragmatic tissue are critically needed for this paediatric surgery. The clinical efficacy of mesh patches is limited by complications associated with residual foreign material and by hernia recurrence. In this study, we used a novel bio-3D printer method to generate large scaffold-free tissue patches composed of human cells. The resulting large tissue constructs had high elasticity and strength. Cellular patches were transplanted into rats with surgically created diaphragmatic defects. Rats survived for over 710 days after implantation of tissue constructs. CT confirmed complete tissue integration of the grafts during rat growth. Histology revealed regeneration of muscle structure, neovascularization, and neuronal networks within the reconstructed diaphragms. Our results demonstrate that created cellular patches are a highly safe and effective therapeutic strategy for repairing diaphragmatic defects, and thus pave the way for a clinical trial.
- Published
- 2018
- Full Text
- View/download PDF